In Germany, nervous system medicine sales are forecasted to grow from 2024 onwards, increasing steadily from 6.02 billion Euros in 2024 to 6.39 billion Euros in 2028. Comparing this data with Koyro's 2023 sales, a consistent year-on-year growth of approximately 1.5% per annum is anticipated throughout this period. The compound annual growth rate (CAGR) over the five-year forecast period is projected to be around 1.5%, indicating a stable yet modest increase in market demand.
Future trends to watch include advancements in biotechnology and personalized medicine, which could enhance treatment efficacy and expand the market. Additionally, the rising prevalence of nervous system-related conditions and increased healthcare investment could further boost sales in this sector.
